Joint Injection at Vanfo Hino Clinic

Non Surgical Knee Regeneration

Mesenchymal stem cell (MSC) therapy is a regenerative medicine approach that involves using stem cells to promote tissue repair and regeneration. In the case of knee problems, MSC therapy may be used to treat conditions such as osteoarthritis, meniscus tears, and ligament injuries without the need for surgery.

MSCs derived from umbilical cord Wharton's jelly are a promising source of stem cells for regenerative medicine, including the treatment of knee problems. Wharton's jelly is a gelatinous substance found in the umbilical cord, and MSCs derived from this tissue have unique properties that make them ideal for clinical use.

Studies have shown that Wharton's jelly-derived MSCs have a high proliferation rate, meaning they can rapidly multiply and produce large numbers of cells for therapeutic use. These cells also have a high degree of potency and can differentiate into various cell types, including chondrocytes (cartilage cells) and osteoblasts (bone cells), which are important for the regeneration of knee tissue.

The treatment process for using Wharton's jelly-derived MSCs for knee problems typically involves harvesting the cells from a donor's umbilical cord and then injecting them into the affected knee joint. The cells can then differentiate into the necessary cell types to repair the damaged tissue and also secrete growth factors that promote tissue regeneration and reduce inflammation.

Research has shown that Wharton's jelly-derived MSC therapy can be effective in treating knee problems. A study published in the Journal of Translational Medicine in 2019 found that Wharton's jelly-derived MSC therapy was effective in reducing pain and improving knee function in patients with knee osteoarthritis. Another study published in the Journal of Orthopaedic Research in 2020 found that Wharton's jelly-derived MSC therapy was effective in promoting cartilage repair in patients with knee osteoarthritis.

It is important to note that while Wharton's jelly-derived MSC therapy is a promising approach for treating knee problems, it is still a developing field and further research is needed to determine its long-term safety and effectiveness. Additionally, it is important to consult with a qualified healthcare provider to determine if Wharton's jelly-derived MSC therapy is appropriate for your individual situation.

Vanfo Hino Clinic, located in Puteri Harbour, Johor, Malaysia offers patients Joint Injection procedures among its total of 4 available procedures, across 4 different specialties

. The cost of a Joint Injection procedure ranges from $5,000 to $10,000, whilst the national average price is approximately $5,000.

All procedures and treatments are undertaken by just a small team of specialists, with 2 in total at the Clinic, and they have multiple recognized accreditations, including:

MMC - Malaysian Medical Council
AMM - Academy of Medicine of Malaysia

Joint Injection at Vanfo Hino Clinic

Joint Injection at Vanfo Hino Clinic

Facility Services Available at Vanfo Hino Clinic